$RLFTF Here it is. It stops replication of the vi
Post# of 653
Quote:
aviptadil is shown as the first COVID therapeutic to block replication of the SARS-CoV-2 virus in human lung cells and monocytes while also preventing synthesis of cytokines in the lung. It is a patented formulation of aviptadil (synthetic human Vasoactive Intestinal Polypeptide, VIP), which has been granted FDA fast track designation, FDA emergency use IND authorisation, and an expanded access protocol.
https://www.thechronicleherald.ca/news/world/...ts-481945/
$RLFTF